Sign in

ITPC Global

@itpc.bsky.social
139 followers 26 following 270 posts

ITPC is an issue-based global organization working to achieve health and social justice for all through robust community engagement.

PostsRepliesMedia
ITPC Global @itpc.bsky.social · 25/09/2026
Why do some countries pay much more than international buyers for the same #HIV medicine? Our new report exposes the patent monopolies, single-supplier contracts & procurement barriers keeping treatment prices high. Read more makemedicinesaffordable.org/new-report-p... #MedicineEqualityNow
makemedicinesaffordable.org
New Report: Patent Monopolies, Single-Supplier Procurement and Volumes Fragmentation Are Driving Up HIV Medicine Costs - Make Medicines Affordable
The 2021–2024 HIV Market Intelligence Report examines the procurement, pricing and regulatory environments for antiretroviral medicines in six countries: Argentina, Armenia, Belarus, Brazil, Kazakhsta...
010
Reposted by ITPC Global
AVAC @avac.org · 23/09/2026
“The future of AI in HIV should be shaped with communities, not simply built from data about them.” — Solange Baptiste, @itpc.bsky.social The latest AI + HIV newsletter explores #AIDS2026 rx, emerging tools, governance, equity and accountability. 🔗 Read the issue: avac.org/ai-hiv-issue2/
012
ITPC Global @itpc.bsky.social · 18/09/2026
What does it take to challenge a pharmaceutical patent? In the latest #MakeMedicinesAffordable podcast, we look at Morocco’s first patent opposition, the challenge to baricitinib & how patent oppositions can help open the door to affordable generics. open.spotify.com/episode/3jdl...
open.spotify.com
How Patent Oppositions Make Medicines Affordable
Make Medicines Affordable · Episode
000
ITPC Global @itpc.bsky.social · 16/09/2026
”We are at risk of creating a two-tier system for access to the next generation of HIV technologies." @omellouk.bsky.social (ITPC) speaking yesterday at the @who.int / @unitaid.bsky.social / @unaids.org Annual Consultation on Access to HIV, TB, Hepatitis and STIs Medicines.
100
ITPC Global @itpc.bsky.social · 14/09/2026
Reminder: Webinar happening this Wed (16th September) discussing how to make difficult funding and reprioritization decisions while keeping communities at the centre. Join @iasociety.bsky.social and ITPC Register here: us06web.zoom.us/webinar/regi...
us06web.zoom.us
Welcome! You are invited to join a webinar: Prioritization under pressure: Bringing communities to the centre of HIV programme decisions. After registering, you will receive a confirmation email about...
Discover a new tool that supports transparent, evidence-informed prioritization decisions and empowers communities through access to the same data and decision-making insights. Join IAS – the Interna...
001
ITPC Global @itpc.bsky.social · 02/09/2026
A revolution in cancer treatment? Or just a revolution in how much a company can charge for a medicine? Scientific breakthroughs should save lives, not come with luxury price tags. Medicines are not luxury goods. They are public goods. nytimes.com/2026/08/31/b... 📸Kim Raff, The New York Times
011
ITPC Global @itpc.bsky.social · 02/09/2026
As the funding landscape continues to change, are you often left wondering how to make difficult funding and reprioritization decisions while keeping communities at the centre? Join @iasociety.bsky.social and ITPC for an interactive webinar. Register here: us06web.zoom.us/webinar/regi...
001
ITPC Global @itpc.bsky.social · 17/08/2026
#AIDS2026 @benplumley.bsky.social @ashotinthearm.bsky.social speaks to @solangebap.bsky.social & @omellouk.bsky.social about funding cuts, long-acting technologies, equitable access & why prevention vs treatment framing is false. 🎧 www.youtube.com/watch?v=MyXw...
youtube.com
Communities & Treatment Access with ITPC at AIDS 2026
YouTube video by A Shot in the Arm Podcast (shotarmpodcast)
013
ITPC Global @itpc.bsky.social · 14/08/2026
Children make up just 3% of people living with HIV, but account for 12% of AIDS-related deaths. Around 2.4M children and adolescents live with HIV globally. Access matters. itpcglobal.org/2026/08/14/c...
itpcglobal.org
Civil society groups in Argentina and Vietnam challenge patents on paediatric dolutegravir - ITPC Global
Fundación GEP and the Viet Nam Network of People Living with HIV (known as VNP+), members of the Make Medicines Affordable campaign, have filed oppositions against patent applications by ViiV Healthca...
001
ITPC Global @itpc.bsky.social · 03/08/2026
What does Gilead’s voluntary license for #lenacapavir mean for global #HIVprevention access? @msf.org experts unpack pricing, supply constraints & why many countries could be left behind. 🎙️Listen now open.spotify.com/episode/5Klc... #MakeMedicinesAffordable
010
ITPC Global @itpc.bsky.social · 29/07/2026
Two ITPC presentations. One argument. Sergiy Kondratyuk on IP barriers, live from Ukraine. Rm 202, 10:30 BRT. @solangebap.bsky.social on AI and HIV service delivery. Rm 201, 12:00 BRT. At 12:15: something is happening at Pharma Privé. Be there. #AIDS2026 #MakeMedicinesAffordable
021
Reposted by ITPC Global
IAS - the International AIDS Society @iasociety.bsky.social · 29/07/2026
☀️ Day 4 of #AIDS2026 starts now! From groundbreaking science to community-led solutions and policy discussions, another full day of learning and collaboration awaits, with more than 50 sessions across #Rio. 🔎 Plan your day with today's Daily Digest: zurl.co/6tosw
iasociety.org
Daily Digest: Wednesday, 29 July | AIDS 2026
We are more than halfway through AIDS 2026! The Daily Digest is your trusted resource throughout the conference. The first of two AIDS 2026 special sessions takes place at lunchtime today. These sessions address timely, urgent issues in HIV science and policy. Quick links Online programme Virtual platform Conference website Coming up today Convert to your time zone through the AIDS 2026 programme. All times in the programme are in Brasilia Time (BRT) 08:30Kick off your day with the plenary, “The future of HIV prevention”, and find out more about the road ahead for vaccine science, the state of art for PrEP, and access to gender-affirming care. The session concludes with the award ceremony of the CIPHER Research Grant Programme. 10:00Workshops translate HIV infectious disease modelling for non-specialists, and frame community-based chemsex psychosis awareness and prevention as a form of care and adherence support. 10:30 The Co-Chairs’ Choice session features the real-world impact of PEPFAR funding disruptions across 46 countries. It includes results of a once-weekly oral HIV treatment and early results on whether a twice-yearly antibody injection can prevent HIV acquisition in African women. The session concludes with the presentation of the IAS President’s Award. The oral abstract session, “Cure and control”, introduces us to the Kansas City patient, in HIV remission after a CCR5Δ32 stem-cell transplant, as well as early promise for N-803, a next-generation immune stimulant, in reducing the intact HIV reservoir. Sessions also look at closing gaps in the prevention of perinatal transmission and overcoming intellectual property barriers to accessing HIV tools. Symposia examine leadership to protect the gains and advance progress in a new era while balancing global solidarity and national sovereignty, and the implications of growing sexual and gender identity fluidity for the HIV response. 12:00 Satellite symposia take place in two time slots: 12:00 and 18:00. At 12:00, join MSD for a medical education symposium on ARV resistance, cardiometabolic health and HIV care for older adults. Workshops explore the responsible use of AI and digital tools in HIV programmes, and legal gender recognition as a structural HIV intervention for trans communities. The regional networking event for IAS Members from Asia and the Pacific Islands takes place at the IAS booth (#901) in the exhibition area. 13:30 New and old challenges threaten gains in HIV treatment and prevention, while new technologies offer the chance to transform care. Today’s special session, “After the emergency: Rebuilding sustainable access to HIV treatment and prevention”, asks what it will take to rebuild equitable access and what governments, donors, civil society and others must do to get there. 14:30 Want to learn how to turn your research into real-world impact by communicating science clearly and accurately for wide audiences? Attend this workshop led by expert researchers and science communicators. Or find out about using data visualization to improve access to public health data for HIV service planning and policy making. 15:00 Symposia bring together community leadership and the science of protection. A session asking us to move beyond resilience and actively resist stigma and discrimination for key populations in healthcare settings concludes with the naming of the IAS Me and my Healthcare Provider champions. In an anti-vax world, people living with HIV face compounded barriers to life-saving immunizations; examine how stigma, misinformation and inequality are driving gaps in vaccine coverage, and what it will take to close them. The Indigenous experience and its intersections with HIV takes centre stage. Young activists and service providers describe what has to change to build an HIV response fit for a new era. The oral abstract session, “ARTistic strategies 2: The long game”, includes a presentation of the first complete safety and efficacy data on twice-yearly HIV treatment for up to 104 weeks. Sessions also focus on the power of communities in delivering HIV services in conflict, humanitarian and development settings, overcoming legal and policy barriers to HIV services, and health interventions in chemsex contexts. 16:30 Find out about PrEP in motion – who stays and who leaves PrEP use – in an oral abstract session. Also under the spotlight are advanced HIV disease and intersecting stigma. A panel weighs in on the promise and potential pitfalls of bNAbs for HIV cure in a symposium. Three symposia tackle funding and political pressures on the HIV response: rethinking systems and synergies to build and sustain service delivery networks, strengthen efficiency and preserve access to care; safeguarding spaces and services for key populations amid geopolitical challenges and shrinking budgets; and rewiring the HIV response in an era when data alone is not enough to drive action. The Global Village Explore the Global Village through the Scavenger Hunt. Among many other exciting activities: “Engaging Islamic faith leaders to reduce HIV stigma and improve SRHR access for trans and key populations”, exploring how Islamic ethics of compassion, justice and protection of life can support human rights-based HIV responses “LHiV 2 ZERO: Our truth. Our power”, a live performance from the San Francisco LGBT Center and the San Francisco AIDS Foundation “Beyond prompts” on community mapping of machine learning and AI shaping the HIV response The Prison Health Matters networking zone, a space to talk about healthcare and HIV management in prisons The poster exhibition You can meet presenting authors next to their posters from 12:15 to 13:15. Featured posters today include: The experience of women undergoing tissue sampling Preliminary results from the RIO trial on HIV viral control after a bNAb “wash-out” and the relationship to HIV viraemia at dosing Findings on a novel DNA delivery method using lipid nanoparticlesLessons from the Uganda National Trans Forum on protecting choice and introducing lenacapavir for trans and gender-diverse communities amid criminalization Data on the use of AI to predict where vertical HIV transmission is taking place Disruptions to HIV prevention services for trans adults after the US federal executive orders Just launched! JIAS supplement, “Towards elimination of sexually transmitted infections: Research developments and vaccine uptake”. It brings together global perspectives on advancing STI vaccine development and implementation, highlighting both scientific progress and the structural, behavioural and stigma-related barriers that shape vaccine uptake. Read it for free The exhibition The exhibition is open from 09:30 to 17:30. Explore cutting-edge products and services and chat with people from key organizations in the HIV response. Rapporteur summaries These are your go-to resources for highlights of AIDS 2026. Thanks to the AIDS 2026 team of expert rapporteurs, you can find daily recaps by each scientific track here. Meet our change makers Silvia Okoth, an Advocacy and Policy Manager for the Bar Hostess Empowerment & Support Programme in Kenya, designs and implements community-led sexual and reproductive health programmes. With the support of the IAS Youth Hub Seed Grant Programme, Silvia manages a project that provides weekly medical outreach measures to young women and girls living on dumpsites. She takes part in the young leaders symposium at 15:00 today. Official media partners Join the conversation The official theme of AIDS 2026 is Rethink. Rebuild. Rise. Share your story or message of support using #RethinkRebuildRise! Follow us on social media, explore the AIDS 2026 social toolkit for ready-to-use posts and graphics, and join the conference conversation. #AIDS2026 @AIDS_conference @International AIDS Conference @aids_conference @International AIDS Society @iasociety Thanks to our major industry sponsors
011
Reposted by ITPC Global
AVAC @avac.org · 28/07/2026
"We need a community governance layer built into the AI ecosystem - one that ensures communities help shape priorities & hold systems accountable” - @itpc.bsky.social's Solange Baptiste @ “AI & HIV: Who owns the future of public health". See our #AIDS2026 #AIHIV roadmap, avac.org/wp-content/u...
012
ITPC Global @itpc.bsky.social · 28/07/2026
A year’s supply of the monthly PrEP pill alimatravir could cost just $3 to make. Yet Merck’s licence excludes Brazil & other countries with high HIV rates, restricting access to affordable generics. This is not equitable access. itpcglobal.org/2026/07/28/a... @abiaids.bsky.social
itpcglobal.org
Alimatravir Should Cost $3 a Year: A Voluntary License Won't Get Us There - ITPC Global
Merck's early voluntary license (VL) for alimatravir (MK-8527) is being sold as a breakthrough in access, but it isn’t - it is the same corporate-controlled mechanism that continues to fail our commun...
010
ITPC Global @itpc.bsky.social · 28/07/2026
No retreat, no surrender: The future of philanthropy in HIV 15:00-16:00 • Room 201 - communities need to be in the room. #AIDS2026
001
ITPC Global @itpc.bsky.social · 28/07/2026
AI and HIV: Who owns the future of public health? Communities do. If we let them. Room 203, Riocentro 13:30-14:40z join us now. #AIDS2026
011
ITPC Global @itpc.bsky.social · 28/07/2026
CLM is a tool to redistribute power… CLM is not a cost; it is an investment in health democracy. - José-Maria Di Bello #AIDS2026
001
ITPC Global @itpc.bsky.social · 28/07/2026
How do you fund CLM when fiscal space is shrinking? How do you generate data when civic space is closing? How do you turn evidence into policy when the political environment is working against you? Those are the questions on the table at SY03 10:30 in Rm 204 #AIDS2026
021
Reposted by ITPC Global
STOPAIDS @stopaids.bsky.social · 28/07/2026
Don't miss our amazing event as part of the HEAR CSO consortium!
012
ITPC Global @itpc.bsky.social · 28/07/2026
#AIDS2026 has begun. Rio de Janeiro. 8000 people. One question: who gets access to the medicines that can end AIDS, who is locked out and who decides? ITPC is here. In the sessions, in the Global Village, anywhere communities need us. #RethinkRebuildRise
011
ITPC Global @itpc.bsky.social · 26/07/2026
“I’m not afraid to be arrested; I’m afraid to lose all that we’ve fought for.” Mari Chokheli, TB People, Georgia. Communities have been here before. The crisis looks different. The stakes are the same. #AIDS2026
111
ITPC Global @itpc.bsky.social · 26/07/2026
The Treatment pre-conference has begun. Before #AIDS2026 begins, communities take center stage. HIV treatment is at a crossroads. Who controls innovation & who gets access? @solangebap.bsky.social @kristalauer.bsky.social @charlene-omrawo.bsky.social @omellouk.bsky.social @abiaids.bsky.social
001
ITPC Global @itpc.bsky.social · 26/07/2026
At the #AIDS2026 Treatment Pre-conference, communities will take stock of the HIV movement, challenge patent barriers & explore how AI is reshaping health. One question connects it all: who controls innovation & who gets access? @unitaid.bsky.social @abiaids.bsky.social @iasociety.bsky.social
021
ITPC Global @itpc.bsky.social · 25/07/2026
What does global health architecture reform mean for the HIV response? Join community leaders and global health experts at #AIDS2026 @wacihealth.bsky.social @stopaids.bsky.social @csem4uhc.bsky.social @gnpplus.bsky.social @gfanafrica.bsky.social @solangebap.bsky.social
022
ITPC Global @itpc.bsky.social · 24/07/2026
💊Thai HIV network TNP+ has opposed a patent application linked to monthly oral PrEP candidate MK-8527, arguing it lacks novelty and could restrict future competition and affordable access to #HIVprevention. Read more makemedicinesaffordable.org/thai-hiv-org...
makemedicinesaffordable.org
Thai HIV Organization Challenges Patent Application to Safeguard Future Access to HIV Prevention Pill MK-8527 - Make Medicines Affordable
Thai HIV network TNP+ has opposed Merck’s MK-8527 patent application, arguing it could restrict future access to affordable monthly oral HIV prevention.
000
ITPC Global @itpc.bsky.social · 24/07/2026
Attending #AIDS2026 in Rio? Bring your white coat from Munich 2024. Communities will be taking action at the conference. Wear it with us.
001
Reposted by ITPC Global
STOPAIDS @stopaids.bsky.social · 21/07/2026
Global health architecture reform is here. Decisions now will shape systems for years to come. Communities must shape what comes next. Take the survey by 31 July! 🔗 bit.ly/HEARCSOsurvey @wacihealth.bsky.social @csem4uhc.bsky.social @itpc.bsky.social @gnpplus.bsky.social @gfanafrica.bsky.social
032
ITPC Global @itpc.bsky.social · 23/07/2026
Innovation without access is an aspiration, not a strategy. ITPC arrives at #AIDS2026 with 25 years of evidence, argument, and community power. Save the roadmap. Follow along all week. @solangebap.bsky.social @omellouk.bsky.social @charlene-omrawo.bsky.social @kristalauer.bsky.social
143
ITPC Global @itpc.bsky.social · 17/07/2026
Kenya has begun rolling out injectable #HIVprevention with #lenacapavir but access is still limited. Maureen Mung’asia, Clinical Team Lead at CIHEB Kenya shares what providers are seeing on demand, stigma, training & supply uncertainty. 🎧Listen here open.spotify.com/episode/6SkV...
000
ITPC Global @itpc.bsky.social · 10/07/2026
Communities are challenging unmerited patents, pushing for law reform, holding decision makers accountable. When communities and governments work together, real progress is possible. Read the full report 👉 itpcglobal.org/resource/we-... #MakeMedicinesAffordable
itpcglobal.org
We are activists: ITPC Annual Review 2025 - ITPC Global
Following the 2025 withdrawal of US funding, community systems stepped in to fill in the gaps in global health infrastructure. Documenting crises in real time, activists shifted from shock to strategy...
000
ITPC Global @itpc.bsky.social · 10/07/2026
Activists. Researchers. Governments. Marrakech, 2025. One message: access to medicine is not a privilege. It is a right worth fighting for. Watch @omellouk.bsky.social youtube.com/shorts/-NhDi...
youtube.com
Access to Medicine Is Not a Privilege. It Is a Right. | MMA 2025 Annual Report
YouTube video by ITPC Global
000
ITPC Global @itpc.bsky.social · 10/07/2026
A breakthrough in HIV prevention, the long-acting injectable #lenacapavir, is here. But will it reach those who need it most? @avac.org's Mitchell Warren talks about the promise, funding challenges & what it will take to ensure equitable access. open.spotify.com/episode/3qOt...
011
Reposted by ITPC Global
AVAC @avac.org · 08/07/2026
A great podcast discussion with AVAC's ED on the future of #PrEP and what it will take to ensure #lenacapavir reaches the people who need it most.
032
ITPC Global @itpc.bsky.social · 07/07/2026
🎧Amid funding cuts & fragile systems, can #lenacapavir for #HIVprevention succeed? AVAC's Mitchell Warren discusses. Listen here👉https://open.spotify.com/episode/3qOtXEmfmxmK2iVXmL7UjS #PrEP #MakeMedicinesAffordable @avac.org
010
ITPC Global @itpc.bsky.social · 30/06/2026
Global health architecture reform is underway. Decisions being made now will shape systems, funding & governance for years to come. Communities & civil society must help shape what comes next. That starts with a collective vision. Take the survey by 31 July! 🔗 bit.ly/HEARCSOsurvey
bit.ly
Enketo Express for KoboToolbox
000
ITPC Global @itpc.bsky.social · 24/06/2026
🌍 ITPC's AI Survey for Communities is now in English, French, Spanish and Russian. We've extended the survey to 5 July to make sure every community voice is heard. 10 mins. 100% anonymous. 👉 shorturl.at/hoqW1 #CommunityIntelligence
000
ITPC Global @itpc.bsky.social · 23/06/2026
WATCH: ITPC’s @solangebap.bsky.social addresses the UN HIV High-Level Meeting plenary, New York, 23 June 2026. youtu.be/bL4yP5rjuZo #HLM2026AIDS #EndAIDS
youtu.be
"Treatment access is a political choice." | Solange Baptiste at the UN General Assembly 2026
YouTube video by ITPC Global
110
ITPC Global @itpc.bsky.social · 22/06/2026
Communities need access, not just announcements. Every major gain in the HIV response was hard fought for by communities. None of it was handed to us. The future of the HIV response will not be determined by what is possible, it will be determined by what political leaders choose to do.
youtu.be
Communities need access, not just announcements | Solange Baptiste - UN HIV High-Level Meeting 2026
YouTube video by ITPC Global
023
ITPC Global @itpc.bsky.social · 22/06/2026
Communities need access, not just announcements. The UN HIV High-Level Meeting is today. ITPC’s @solangebap.bsky.social is in the room challenging world leaders on medicines access, IP barriers, financing, and community leadership. Read our statement 👉 shorturl.at/0etwx #HLM2026AIDS
shorturl.at
ITPC statement on the political declaration on HIV: Hold the Line. Finish the Job. - ITPC Global
Today, world leaders gather at the United Nations for the 2026 High-Level Meeting on HIV/AIDS. The global HIV response has saved millions of lives and become one of the greatest public health achievem...
000
ITPC Global @itpc.bsky.social · 19/06/2026
NEW TOOLKIT: The Global Fund GC8 window is open. Community engagement can't stop at proposal submission. ITPC Global's new guide covers the full cycle, from NSP updates to grant approval. Even in shrinking fiscal space, community power must expand. 👉 shorturl.at/Y1CvM
shorturl.at
NEW TOOLKIT LAUNCH: Strengthening Community Action in Global Fund GC8 (2027–2030) - ITPC Global
A critical shift is underway in global health financing. As fiscal pressures intensify across low- and middle-income countries and debt burdens continue to rise, the space for health investment is nar...
100
ITPC Global @itpc.bsky.social · 19/06/2026
A TB drug that could cost US $30 per treatment course costs up to $1,700. #MakeMedicinesAffordable partners in 7 countries are fighting back, challenging evergreening patents on delamanid to open the door to affordable generics. 👉 shorturl.at/YJVQk
shorturl.at
Thailand, Ukraine, and Uzbekistan Fight Delamanid Monopolies in an Effort to Expand Affordable TB Treatment - Make Medicines Affordable
MMA partner organizations in Uzbekistan, Thailand and Ukraine have filed patent oppositions against applications covering delamanid, an antibiotic used to...
000
ITPC Global @itpc.bsky.social · 18/06/2026
⚡We're hiring⚡ ITPC is seeking a Legal Consultant (Moldova/Morocco). To find out more and to apply visit 👉 shorturl.at/eOWUW #jobopportunities #careeropportunity
shorturl.at
Terms of Reference for Legal Consultant (Moldova/Morocco) - ITPC Global
Background ITPC was birthed in 2003 in Cape Town, South Africa, by a committed group of 125 HIV activists from 65 countries who refused to accept a world in which people living with HIV were denied ac...
000
ITPC Global @itpc.bsky.social · 18/06/2026
When US funding cuts hit in 2025, our community-led monitoring teams were already in the field. They pivoted fast, turning data into decisions that kept people alive. Watch @kristalauer.bsky.social 👇 shorturl.at/T2N2C
youtube.com
From Data to Decisions How Communities Led the Response in 2025
YouTube video by ITPC Global
100
ITPC Global @itpc.bsky.social · 17/06/2026
The US spends more on healthcare than any other country. So why do so many people living with or affected by HIV still struggle to access care? 🎧 New podcast episode out now. 👉https://shorturl.at/fm6Ah #HIV #MakeMedicinesAffordable
000
ITPC Global @itpc.bsky.social · 11/06/2026
In 2025, communities grieved. Lost programs, lost services, lost loved ones. And then they organized, gathered evidence, and kept people alive. Watch Executive Director @solangebap.bsky.social explain why. 👇 youtu.be/vnGSzbNqUGU
youtu.be
From Shock to Strategy: Solange Baptiste on ITPC's 2025 Annual Report
YouTube video by ITPC Global
100
ITPC Global @itpc.bsky.social · 11/06/2026
Innovation without access is not progress. It is inequality. At the Future of HIV Markets Forum in Nairobi, ITPC called for a redesign of the rules — so public health, not commercial strategy, drives medical innovation. #MakeMedicinesAffordable
000
ITPC Global @itpc.bsky.social · 10/06/2026
📍 Lilongwe, Malawi. Governments, civil society and partners gathered for the COMET CLM Workshop this week. Community intelligence is not supplementary data. It is the foundation of health reform.
100
ITPC Global @itpc.bsky.social · 10/06/2026
🌍 The Global AI Survey is now in French and English. Spanish and Russian coming soon. We've extended the survey to make sure every community voice is heard. Closes 30 June. 10 mins. 100% anonymous. Make sure yours is in the data. 👉 shorturl.at/hoqW1 #CommunityIntelligence #CommunitiesAreExperts
000
ITPC Global @itpc.bsky.social · 09/06/2026
Big Pharma has mastered evergreening. Now not just patents, but clinical development itself is the tool. Every year of unnecessary exclusivity costs lives. At the Future of HIV Markets Forum in Nairobi, ITPC is calling it out. #MakeMedicinesAffordable
000
ITPC Global @itpc.bsky.social · 03/06/2026
SAVE THE DATE: #AIDS2026 Treatment Pre-conference Funding cuts. New technologies. Growing inequalities. The HIV response is at a crossroads. Register for updates on the pre-conference at 👉 shorturl.at/kw2Xn #MakeMedicinesAffordable #RethinkRebuildRise
011